Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term immunology. Found 221 abstracts

no pagination
Dash PK, Kaminski R, Bella R, Su H, Mathews S, Ahooyi TM, Chen C, Mancuso P, Sariyer R, Ferrante P, Donadoni M, Robinson JA, Sillman B, Lin Z, Hilaire JR, Banoub M, Elango M, Gautam N, Mosley RL, Poluektova LY, McMillan J, Bade AN, Gorantla S, Sariyer IK, Burdo TH, Young WB, Amini S, Gordon J, Jacobson JM, Edagwa B, Khalili K, Gendelman HE. Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice. Nat Commun. 2019 Jul 02;10(1):2753.   PMCID: PMC6606613
Ji Y, Fioravanti J, Zhu W, Wang H, Wu T, Hu J, Lacey NE, Gautam S, Le Gall JB, Yang X, Hocker JD, Escobar TM, He S, Dell'Orso S, Hawk NV, Kapoor V, Telford WG, Di Croce L, Muljo SA, Zhang Y, Sartorelli V, Gattinoni L. miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8(+) T cell fate. Nat Commun. 2019 May 14;10(1):2157.   PMCID: PMC6517388
Shen H, Wu N, Nanayakkara G, Fu H, Yang Q, Yang WY, Li A, Sun Y, Drummer Iv C, Johnson C, Shao Y, Wang L, Xu K, Hu W, Chan M, Tam V, Choi ET, Wang H, Yang X. Co-signaling receptors regulate T-cell plasticity and immune tolerance. Frontiers in bioscience (Landmark edition). 2019 Jan;24:96-132.   PMCID: PMC6309335
Adolf-Bryfogle J, Kalyuzhniy O, Kubitz M, Weitzner BD, Hu X, Adachi Y, Schief WR, Dunbrack RL. RosettaAntibodyDesign (RAbD): A general framework for computational antibody design. PLoS computational biology. 2018 Apr 27;14(4):e1006112.   PMCID: PMC5942852
Gerson JN, Ramamurthy C, Borghaei H. Managing adverse effects of immunotherapy. Clinical advances in hematology & oncology : H&O. 2018 May;16(5):364-74.   PMCID: Review
Hahn NM, Necchi A, Loriot Y, Powles T, Plimack ER, Sonpavde G, Roupret M, Kamat AM. Role of Checkpoint Inhibition in Localized Bladder Cancer. European urology oncology. 2018 Aug;1(3):190-8.
Lee MH, Chakhtoura M, Sriram U, Caricchio R, Gallucci S. Conventional DCs from Male and Female Lupus-Prone B6.NZM Sle1/Sle2/Sle3 Mice Express an IFN Signature and Have a Higher Immunometabolism That Are Enhanced by Estrogen. Journal of immunology research. 2018 Apr;2018:1601079.   PMCID: PMC5925037
Lyu Z, Kang L, Buuh ZY, Jiang D, McGuth JC, Du J, Wissler HL, Cai W, Wang RE. A Switchable Site-Specific Antibody Conjugate. ACS chemical biology. 2018 Apr 20;13(4):958-64.   PMCID: PMC5910183
Marty Pyke R, Thompson WK, Salem RM, Font-Burgada J, Zanetti M, Carter H. Evolutionary Pressure against MHC Class II Binding Cancer Mutations. Cell. 2018 Oct 04;175(2):416-428e13.   PMCID: PMC6482006
Shemesh A, Brusilovsky M, Kundu K, Ottolenghi A, Campbell KS, Porgador A. Splice variants of human natural cytotoxicity receptors: novel innate immune checkpoints. Cancer immunology, immunotherapy : CII. 2018 Dec;67(12):1871-83.
Zhou R, Wang X, Liu H, Guo L, Su Q, Wang H, Vasiliadis T, Ho W, Li J. GalNAc-Specific Soybean Lectin Inhibits HIV Infection of Macrophages through Induction of Antiviral Factors. J Virol. 2018 Mar 15;92(6).   PMCID: PMC5827391
Aras S, Zaidi MR. TAMeless traitors: macrophages in cancer progression and metastasis. Br J Cancer. 2017 Oct 24;117(11):1583-91.   PMCID: PMC5729447
Bauman JE, Cohen E, Ferris RL, Adelstein DJ, Brizel DM, Ridge JA, O'Sullivan B, Burtness BA, Butterfield LH, Carson WE, Disis ML, Fox BA, Gajewski TF, Gillison ML, Hodge JW, Le QT, Raben D, Strome SE, Lynn J, Malik S. Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting. Cancer. 2017 Apr;123(7):1259-71.   PMCID: PMC5705038
Dmitrieva O, Grivennikov SI. Microbiota and cancer: a complex equation with a lot of exciting unknowns. Seminars in immunology. 2017 Aug;32:1-2.   PMCID: Editorial
Gallucci S, Maffei ME. DNA Sensing across the Tree of Life. Trends in immunology. 2017 Oct;38(10):719-32.   PMCID: Review
Hooper KM, Yen JH, Kong W, Rahbari KM, Kuo PC, Gamero AM, Ganea D. Prostaglandin E2 Inhibition of IL-27 Production in Murine Dendritic Cells: A Novel Mechanism That Involves IRF1. J Immunol. 2017 Feb 15;198(4):1521-30.   PMCID: PMC5296337
Huang Q, He S, Tian Y, Gu Y, Chen P, Li C, Huang J, Liu Y, Yu H, Jin M, Hu S, Tong Q, Ma A, Jin J, Hexner E, Fung H, Reshef R, Zhang Y, Zhang Y. Hsp90 inhibition destabilizes Ezh2 protein in alloreactive T cells and reduces graft-versus-host disease in mice. Blood. 2017 May 18;129(20):2737-48.   PMCID: PMC5437825
Kearns A, Gordon J, Burdo TH, Qin X. HIV-1-Associated Atherosclerosis: Unraveling the Missing Link. Journal of the American College of Cardiology. 2017 Jun 27;69(25):3084-98.   PMCID: PMC5512584
Kearns A, Gordon J, Burdo TH, Qin X. HIV-1-Associated Atherosclerosis: Unraveling the Missing Link. Journal of the American College of Cardiology. 2017 Jun 27;69(25):3084-98.   PMCID: PMC5512584
Marty R, Kaabinejadian S, Rossell D, Slifker MJ, van de Haar J, Engin HB, de Prisco N, Ideker T, Hildebrand WH, Font-Burgada J, Carter H. MHC-I Genotype Restricts the Oncogenic Mutational Landscape. Cell. 2017 Nov 30;171(6):1272-1283 e15.   PMCID: PMC5711564
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term immunology

immunology genetics metabolism Mice etiology methods Signal Transduction Neoplasms HIV Infections therapy virology drug therapy Macrophages Immunotherapy administration & dosage immunotherapy epidemiology antagonists & inhibitors pathology Inbred C57BL Mice chemistry Monoclonal Antibodies drug effects physiology Programmed Cell Death 1 Receptor T-Lymphocytes Gene Expression Profiling macrophage Innate Immunity Dendritic Cells B7-H1 Antigen Cellular Immunity adverse effects diagnosis Morbidity Inflammation Female Tg26 transgenic mice Risk Factors Antibodies Anti-HIV Agents caspase-1 Treatment Outcome pharmacology CD4-Positive T-Lymphocytes Immunologic Factors Immune Tolerance Tumor Microenvironment cytology Survival Rate Cell Differentiation cancer Atherosclerosis immune activation inflammasome Neoplastic Gene Expression Regulation Lymphocyte Activation Hiv-1 therapeutic use Combined Modality Therapy prevention & control complications trends inflammation CD8-Positive T-Lymphocytes Global Health HIV-1 Adoptive Transfer CTLA-4 Antigen diagnostic imaging Spleen Methylation Non-muscle-invasive Neoplastic Stem Cells Mutation checkpoint inhibitors GalNAc IFN-beta 4 Phosphatidylinositol-3-5-Trisphosphate 5-Phosphatases Alternative Splicing Skin Neoplasms cancer susceptibility prediction Age Factors Antigen Receptors-T-Cell Mhc-ii Disease Progression NKp44 head and neck cancer Virus Internalization Complementarity Determining Regions Carcinogenesis Homeostasis Molecular Models Transitional Cell Carcinoma pd-1 microbiology Monte Carlo Method Cell Cycle Checkpoints Switch Genes Toll-Like Receptor 9 transplantation Microbiota Transcriptome Binding Sites Clinical Trials as Topic Interferon-beta pd-l1 Enhancer of Zeste Homolog 2 Protein Hematopoietic Stem Cell Transplantation Hematologic Neoplasms Lupus Nephritis Animal Disease Models Dinoprostone Interleukins Molecular Evolution major histocompatibility complex Histones antigen presentation DNA-Binding Proteins Prostaglandin E Receptors-EP4 Subtype Infection Histocompatibility Antigens Class I biosynthesis ctla-4 Preclinical Drug Evaluation Resorcinols Viral DNA Cultured Cells Estradiol Experimental Melanoma Dermatitis Amino Acid Sequence Regulatory T-Lymphocytes Polycomb Repressive Complex 2 Urinary Bladder Neoplasms statistics & numerical data Graft vs Host Disease HIV Envelope Protein gp41 Immune checkpoints CD40 Antigens Retrospective Studies immune editing Drug Design Protein Domains Cellular Senescence Plant Lectins human papillomavirus Autoantibodies United States Protein Kinase Inhibitors
Last updated on Friday, December 06, 2019